Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant

ABSTRACT

An emulsion cosmetic composition comprising at least one resveratrol derivative, an aqueous phase, and an oil phase, having at least one silicone surfactant, and a method for preparing emulsions capable of delivering active resveratrol to the skin.

This application claims priority from provisional U.S. patentapplication Ser. No. 60/952,878, filed Jul. 31, 2007.

TECHNICAL FIELD

The invention is in the field of emulsion cosmetic compositions forapplication to keratinous surfaces.

BACKGROUND OF THE INVENTION

Resveratrol, also referred to as 3,5,4′-trihydroxystilbene, is apolyhydroxy-substituted compound having the general formula:

It is present in red grapes, raspberries, blueberries, and certain otherplant berries or extracts. It has been reported that resveratrol hasanti-aging, anti-cancer, and antiviral effects. Because of its perceivedfountain-of-youth properties, resveratrol has been incorporated into avariety of cosmetic formulations, such as skin creams. However, oneproblem with resveratrol is that it is generally unstable in cosmeticformulations. Accordingly, if used in cosmetic formulas, it can only beused in very small amounts. If present in too large an amount, theresveratrol will hydrolyze and cause the cosmetic formulation into whichit is incorporated to become discolored.

One way to address the instability of resveratrol is to derivatize theresveratrol by substituting the hydroxy groups at the 3, 5, and 4′position with other functional groups to form resveratrol derivativesthat are more stable in cosmetic formulas. It has been discovered thatresveratrol derivatives of inorganic acids, organic carboxylic acids,mono-, di-, or polysaccharides, or other functional groups are morestable in cosmetic formulations, particularly those in the emulsionform.

It is an object of the invention to provide an emulsion cosmeticcomposition containing at least one resveratrol derivative, preferablyone that is hydrolytically stable in cosmetic formulations that areaqueous based.

It is a further object of the invention to provide an emulsion cosmeticcomposition containing at least one resveratrol derivatives, a waterphase, and an oil phase, and at least one silicone surfactant.

It is a further object of the invention to provide emulsion cosmeticcompositions that are aesthically pleasing and stable compositions thatare commercially acceptable, that is, suitable for use by and sale todiscriminating consumers that have high standards.

It is a further object of the invention to provide emulsion cosmeticcompositions in the form of creams, lotions, serums, gels, foundationmakeups, and the like, containing at least one resveratrol derivative,water, and oil, and at least one silicone surfactant.

SUMMARY OF THE INVENTION

The invention is directed to an emulsion cosmetic composition comprisingat least one resveratrol derivative, an aqueous phase, an oil phase, andat least one silicone surfactant. The oil phase structuring agentcontributes to an aesthetically pleasing emulsion that has a suitabletexture and viscosity. In addition, the silicone surfactant contributesto the feel of the composition when applied as well as the stability ofthe composition, and makes it an appropriate for storage in standardcosmetic containers such as tubes, jars, and the like.

DETAILED DESCRIPTION

The compositions of the invention may be in the water-in-oil oroil-in-water emulsion form. The amount of water may range from about0.1-99%, preferably from about 5-85%, more preferably from about 7-75%by weight of the total composition. The amount of oil will preferablyrange from about 1-95%, preferably from about 5-85%, more preferablyfrom about 7-65% by weight of the total composition.

I. Resveratrol Derivatives

Without being bound by this explanation, it is believed that thepractical use of resveratrol in cosmetic compositions has been limitedby instability due to the phenol groups. The resveratrol derivativesused in the compositions of the invention contain protective groups,which function to stabilize the phenol groups of resveratrol and makethe resveratrol derivative suitable for use in emulsions where superioraesthetics and stability are required for commercially acceptableproducts. In addition, once the compositions containing the derivativeis applied to skin, the protective groups can be easily hydrolyzed fromthe molecule, preferably by enzymes and other ingredients on the skinsurface, to release an active form of resveratrol into the skin.

The resveratrol derivatives of the present invention have a generalformula of:

wherein X, Y, and Z are either hydrogen or a protective group, providedthat at least one of X, Y, and Z is the protective group.

The resveratrol derivatives may be present ranging from about 0.001 to95%, preferably from about 0.005 to 90%, more preferably from about 0.1to 20% by weight of the total composition.

A. Resveratrol Esters of Inorganic Acids

Resveratrol esters of inorganic acids, in which one or more of the X, Y,and Z are inorganic acid functional groups such as phosphates, nitrates,sulfonates, and carbonates, can be used in the present invention.Following is a list of exemplary inorganic acid esters that areparticularly suitable for practice of the present invention:

3-phosphate-5,4′-dihydroxystilbene;

5-phosphate-3,4′-dihydroxystilbene;

4′-phosphate-3,5-dihydroxystilbene;

3,5-diphsophate-4′-hydroxystilbene;

3,4′-diphosphate-5-hydroxystilbene;

4′,5-diphosphate-3-hydroxystilbene;

3,5,4′-triphosphate stilbene;

3-nitrate-5,4′-dihydroxystilbene;

5-nitrate-3,4′-dihydroxystilbene;

4′-nitrate-3,5-dihydroxystilbene;

3,5-dinitrate-4′-hydroxystilbene;

3,4′-dinitrate-5-hydroxystilbene;

4′,5-dinitrate-3-hydroxystilbene;

3,5,4′-trinitrate stilbene;

3-sulfonate-5,4′-dihydroxystilbene;

5-sulfonate-3,4′-dihydroxystilbene;

4′-sulfonate-3,5-dihydroxystilbene;

3,5-disulfonate-4′-hydroxystilbene;

3,4′-disulfonate-5-hydroxystilbene;

4′,5-disulfonate-3-hydroxystilbene;

3,5,4′-trisulfonate stilbene;

3-carbonate-5,4′-dihydroxystilbene;

5-carbonate-3,4′-dihydroxystilbene;

4′-carbonate-3,5-dihydroxystilbene;

3,5-dicarbonate-4′-hydroxystilbene;

3,4′-dicarbonate-5-hydroxystilbene;

4′,5-dicarbonate-3-hydroxystilbene; and

3,5,4′-tricarbonate stilbene.

Pharmaceutically acceptable salts of the above-listed resveratrol esterscan also be used in the cosmetic compositions of the present invention.Such salts may include one or more monovalent or divalent cationsselected from the group consisting of Na, K, Mg, Ca, Fe, and NH₄. Thesalts can be formed by adding corresponding bases, such as sodiumhydroxide, potassium hydroxide, and the like, into a solution containingthe resveratrol esters.

Such inorganic acid esters of resveratrol may be readily formed by wellknown chemical processes that substitute the hydroxyl groups of phenolsor polyphenols with the phosphate, sulfonates, and carbonate functionalgroups. For example, U.S. Pat. No. 4,003,966 describes a one-stepprocess for selectively phosphorylating phenols to form phosphate estersthereof, the contents of which are hereby incorporated herein byreference in its entirety.

Preferred is the 3,4′,5-triphosphate stilbene, also referred to as aresveratrol triphosphate ester having the formula (resveratroltriphosphate):

Phosphate esters of resveratrol, including resveratrol triphosphate, aredisclosed in International Patent Application Publication No. WO2006/029484A1, which is hereby incorporated by reference in itsentirety. Resveratrol triphosphate may be synthesized by the method asset forth in Example 2 of WO 2006/029484A1. More specifically, asolution of resveratrol (3,4,5-trihydroxystilbene) (25 mmols, 5.7 grams)and dimethylaminopyridine (7.5 mmols, 0.93 grams) in 100 ml acetonitrileis cooled under nitrogen up to −10° C. After 10 minutes, carbontetrachloride (375 mmol, 36.2 ml) and DIEA (159 mmol; 27.7 ml) and themixture maintained under stirring for 30 minutes. Dibenzylphosphate (113mmols, 25.0 ml) is added and the mixture stirred for an additional 12hours at room temperature. The course of the reaction is monitored byTLC (silica F254, eluent ethyl acetate/n-hexane 80/20 v/v). One liter of0.5 M KH2PO4 is added, and the mixture then extract with ethyl acetate.The resulting product, tri(dibenzylphosphate) resveratrol, is purifiedby filtration on a silica gel, washing first with a mixture of ethylacetate/n-hexane (80/20 v/v) to remove any remaining unreactedresveratrol, and then with methanol, to obtain a yellow oil.

To the tri(dibenzylphosphate) resveratrol (12.5 mmol) in 200 mL ofanhydrous DCM at 0° C., is added bromomethylsilane (79 mmols, 10.4 mL).After 2 hours, 300 mL of H₂O is added, and the reaction mixture isstirred for 1 hour. The water phase is washed again with ethyl acetate,then lyophilized to obtain an orange oil.

To the product obtained above, solubilized in 400 mL of ethanol, isadded CH₃ONa (37 mmol; 2.03 g) and the reaction stirred for 12 hours atroom temperature. The ethanol is evaporated in a rotavapor, and theresidue solubilized in H₂O. The water phase is washed with ethyl acetateand lyophilized. The mass spectrum of the resulting white solid showsthe presence of resveratrol triphosphate (PM=468.1), with a total yieldof >90% with respect to resveratrol.

If desired the resveratrol triphosphate may be neutralized with organicor inorganic bases such as sodium hydroxide, potassium hydroxide and thelike. Particularly preferred is where the resveratrol triphosphate isneutralized with sodium hydroxide to form trisodium resveratroltriphosphate.

B. Carboxylic Acid Esters of Resveratrol

Another group of resveratrol derivatives that can be used in the presentinvention is esters of resveratrol and carboxylic acids, in which one ormore of X, Y, and Z is a —C(O)—R₁ group, wherein R₁ is selected from thegroup consisting of linear, branched or cyclic C₁-C₄₀ alkyl, substitutedC₁-C₄₀ alkyl, C₁-C₄₀ alkenyl, substituted C₁-C₄₀ alkenyl, C₁-C₄₀alkynyl, substituted C₁-C₄₀ alkynyl, C₁-C₄₀ aryl, and C₁-C₄₀ substitutedaryl. In one preferred embodiment, the R group is a straight or branchedchain fatty, or C₆₋₃₀, saturated or unsaturated alkyl group.

Exemplary carboxylic acids that can be used to form ester of resveratrolinclude, but are not limited to: substituted or unsubstituted saturatedmonocarboxylic acids, such as acetic acid (C2), propionic acid (C3),butyric acid (C4), valeric acid (C5), hexanoic acid (C6), capric acid(C10), caprylic acid (C8), lauric acid (C12), palmitic acid (C16),stearic acid (C18), isostearic acid (branched C18), myristic acid (C14),arachidic acid (C20), and behenic acid (C22); unsaturated monocarboxylicacids, such as acrylic acid (C3), methacrylic acid (C4), sorbic acid(C6), oleic acid (C18 with a single double bond), linoleic acid (C18with two double bonds), linolenic acid (C18 with three double bonds),arachidonic acid (C20 with four double bonds), eicosapentaenoic acid(C20 with five double bonds), erucic acid (C22 with a single doublebond), docosahexaenoic acid (C22 with six double bonds), lipoic acid,;amino acids, such as arginine, glutamine, and tyrosine; keto acids, suchas pyruvic acid and acetoacetic acid; aromatic carboxylic acids, such asascorbic acid, benzoic acid, salicylic acid, and ferulic acid; di- andtri-carboxylic acids, such as oxalic acid, malonic acid, malic acid,succinic acid, and glutaric acid. Also suitable are carboxylic acidssubstituted with cyclic disulfide groups, e.g. lipoic acid. Thedesignation “C” followed by a number indicates the number of carbonatoms in the alkyl chain.

Following is a list of exemplary carboxylic acid esters of resveratrolthat are particularly suitable for practice of the present invention:

3-acetate-5,4′-dihydroxystilbene;

5-acetate-3,4′-dihydroxystilbene;

4′-acetate-3,5-dihydroxystilbene;

3,5-diacetate-4′-hydroxystilbene;

3,4′-diacetate-5-hydroxystilbene;

4′,5-diacetate-3-hydroxystilbene;

3,5,4′-triacetate stilbene;

3-propionate-5,4′-dihydroxystilbene;

5-propionate-3,4′-dihydroxystilbene;

4′-propionate-3,5-dihydroxystilbene;

3,5-dipropionate-4′-hydroxystilbene;

3,4′-dipropionate-5-hydroxystilbene;

4′,5-dipropionate-3-hydroxystilbene;

3,5,4′-tripropionate stilbene;

3-butyrate-5,4′-dihydroxystilbene;

5-butyrate-3,4′-dihydroxystilbene;

4′-butyrate-3,5-dihydroxystilbene;

3,5-dibutyrate-4′-hydroxystilbene;

3,4′-dibutyrate-5-hydroxystilbene;

4′,5-dibutyrate-3-hydroxystilbene;

3,5,4′-tributyrate stilbene;

3-valerate-5,4′-dihydroxystilbene;

5-valerate-3,4′-dihydroxystilbene;

4′-valerate-3,5-dihydroxystilbene;

3,5-divalerate-4′-hydroxystilbene;

3,4′-divalerate-5-hydroxystilbene;

4′,5-divalerate-3-hydroxystilbene;

3,5,4′-trivalerate stilbene;

3-hexanoate-5,4′-dihydroxystilbene;

5-hexanoate-3,4′-dihydroxystilbene;

4′-hexanoate-3,5-dihydroxystilbene;

3,5-dihexanoate-4′-hydroxystilbene;

3,4′-dihexanoate-5-hydroxystilbene;

4′,5-dihexanoate-3-hydroxystilbene;

3,5,4′-trihexanoate stilbene;

3-caprate-5,4′-dihydroxystilbene;

5-caprate-3,4′-dihydroxystilbene;

4′-caprate-3,5-dihydroxystilbene;

3,5-dicaprate-4′-hydroxystilbene;

3,4′-dicaprate-5-hydroxystilbene;

4′,5-dicaprate-3-hydroxystilbene;

3,5,4′-tricaprate stilbene;

3-caprylate-5,4′-dihydroxystilbene;

5-caprylate-3,4′-dihydroxystilbene;

4′-caprylate-3,5-dihydroxystilbene;

3,5-dicaprylate-4′-hydroxystilbene;

3,4′-dicaprylate-5-hydroxystilbene;

4′,5-dicaprylate-3-hydroxystilbene;

3,5,4′-tricaprylate stilbene;

3-laurate-5,4′-dihydroxystilbene;

5-laurate-3,4′-dihydroxystilbene;

4′-laurate-3,5-dihydroxystilbene;

3,5-dilaurate-4′-hydroxystilbene;

3,4′-dilaurate-5-hydroxystilbene;

4′,5-dilaurate-3-hydroxystilbene;

3,5,4′-trilaurate stilbene;

3-palmitate-5,4′-dihydroxystilbene;

5-palmitate-3,4′-dihydroxystilbene;

4′-palmitate-3,5-dihydroxystilbene;

3,5-dipalmitate-4′-hydroxystilbene;

3,4′-dipalmitate-5-hydroxystilbene;

4′,5-dipalmitate-3-hydroxystilbene;

3,5,4′-tripalmitate stilbene;

3-stearate-5,4′-dihydroxystilbene;

5-stearate-3,4′-dihydroxystilbene;

4′-stearate-3,5-dihydroxystilbene;

3,5-distearate-4′-hydroxystilbene;

3,4′-distearate-5-hydroxystilbene;

4′,5-distearate-3-hydroxystilbene;

3,5,4′-tristearate stilbene;

3-isostearate-5,4′-dihydroxystilbene;

5-isostearate-3,4′-dihydroxystilbene;

4′-isostearate-3,5-dihydroxystilbene;

3,5-diisostearate-4′-hydroxystilbene;

3,4′-diisostearate-5-hydroxystilbene;

4′,5-diisostearate-3-hydroxystilbene;

3,5,4′-triisostearate stilbene;

3-myristate-5,4′-dihydroxystilbene;

5-myristate-3,4′-dihydroxystilbene;

4′-myristate-3,5-dihydroxystilbene;

3,5-dimyristate-4′-hydroxystilbene;

3,4′-dimyristate-5-hydroxystilbene;

4′,5-dimyristate-3-hydroxystilbene;

3,5,4′-trimyristate stilbene;

3-arachidate-5,4′-dihydroxystilbene;

5-arachidate-3,4′-dihydroxystilbene;

4′-arachidate-3,5-dihydroxystilbene;

3,5-diarachidate-4′-hydroxystilbene;

3,4′-diarachidate-5-hydroxystilbene;

4′,5-diarachidate-3-hydroxystilbene;

3,5,4′-triarachidate stilbene;

3-behenate-5,4′-dihydroxystilbene;

5-behenate-3,4′-dihydroxystilbene;

4′-behenate-3,5-dihydroxystilbene;

3,5-dibehenate-4′-hydroxystilbene;

3,4′-dibehenate-5-hydroxystilbene;

4′,5-dibehenate-3-hydroxystilbene;

3,5,4′-tribehenate stilbene;

3-acrylate-5,4′-dihydroxystilbene;

5-acrylate-3,4′-dihydroxystilbene;

4′-acrylate-3,5-dihydroxystilbene;

3,5-diacrylate-4′-hydroxystilbene;

3,4′-diacrylate-5-hydroxystilbene;

4′,5-diacrylate-3-hydroxystilbene;

3,5,4′-triacrylate stilbene;

3-methacrylate-5,4′-dihydroxystilbene;

5-methacrylate-3,4′-dihydroxystilbene;

4′-methacrylate-3,5-dihydroxystilbene;

3,5-dimethacrylate-4′-hydroxystilbene;

3,4′-dimethacrylate-5-hydroxystilbene;

4′,5-dimethacrylate-3-hydroxystilbene;

3,5,4′-trimethacrylate stilbene;

3-sorbate-5,4′-dihydroxystilbene;

5-sorbate-3,4′-dihydroxystilbene;

4′-sorbate-3,5-dihydroxystilbene;

3,5-disorbate-4′-hydroxystilbene;

3,4′-disorbate-5-hydroxystilbene;

4′,5-disorbate-3-hydroxystilbene;

3,5,4′-trisorbate stilbene;

3-oleate-5,4′-dihydroxystilbene;

5-oleate-3,4′-dihydroxystilbene;

4′-oleate-3,5-dihydroxystilbene;

3,5-dioleate-4′-hydroxystilbene;

3,4′-dioleate-5-hydroxystilbene;

4′,5-dioleate-3-hydroxystilbene;

3,5,4′-trioleate stilbene;

3-linoleate-5,4′-dihydroxystilbene;

5-linoleate-3,4′-dihydroxystilbene;

4′-linoleate-3,5-dihydroxystilbene;

3,5-dilinoleate-4′-hydroxystilbene;

3,4′-dilinoleate-5-hydroxystilbene;

4′,5-dilinoleate-3-hydroxystilbene;

3,5,4′-trilinoleate stilbene;

3-linolenate-5,4′-dihydroxystilbene;

5-linolenate-3,4′-dihydroxystilbene;

4′-linolenate-3,5-dihydroxystilbene;

3,5-dilinolenate-4′-hydroxystilbene;

3,4′-dilinolenate-5-hydroxystilbene;

4′,5-dilinolenate-3-hydroxystilbene;

3,5,4′-trilinolenate stilbene;

3-arachidonate-5,4′-dihydroxystilbene;

5-arachidonate-3,4′-dihydroxystilbene;

4′-arachidonate-3,5-dihydroxystilbene;

3,5-diarachidonate-4′-hydroxystilbene;

3,4′-diarachidonate-5-hydroxystilbene;

4′,5-diarachidonate-3-hydroxystilbene;

3,5,4′-triarachidonate stilbene;

3-eicosapentaenoic-5,4′-dihydroxystilbene;

5-eicosapentaenoic-3,4′-dihydroxystilbene;

4′-eicosapentaenoic-3,5-dihydroxystilbene;

3,5-dieicosapentaenoic-4′-hydroxystilbene;

3,4′-dieicosapentaenoic-5-hydroxystilbene;

4′,5-dieicosapentaenoic-3-hydroxystilbene;

3,5,4′-trieicosapentaenoic stilbene;

3-erucate-5,4′-dihydroxystilbene;

5-erucate-3,4′-dihydroxystilbene;

4′-erucate-3,5-dihydroxystilbene;

3,5-dierucate-4′-hydroxystilbene;

3,4′-dierucate-5-hydroxystilbene;

4′,5-dierucate-3-hydroxystilbene;

3,5,4′-trierucate stilbene;

3-docosahexaenoate-5,4′-dihydroxystilbene;

5-docosahexaenoate-3,4′-dihydroxystilbene;

4′-docosahexaenoate-3,5-dihydroxystilbene;

3,5-didocosahexaenoate-4′-hydroxystilbene;

3,4′-didocosahexaenoate-5-hydroxystilbene;

4′,5-didocosahexaenoate-3-hydroxystilbene;

3,5,4′-tridocosahexaenoate stilbene;

3-arginate-5,4′-dihydroxystilbene;

5-arginate-3,4′-dihydroxystilbene;

4′-arginate-3,5-dihydroxystilbene;

3,5-diarginate-4′-hydroxystilbene;

3,4′-diarginate-5-hydroxystilbene;

4′,5-diarginate-3-hydroxystilbene;

3,5,4′-triarginate stilbene;

3-glutamate-5,4′-dihydroxystilbene;

5-glutamate-3,4′-dihydroxystilbene;

4′-glutamate-3,5-dihydroxystilbene;

3,5-diglutamate-4′-hydroxystilbene;

3,4′-diglutamate-5-hydroxystilbene;

4′,5-diglutamate-3-hydroxystilbene;

3,5,4′-triglutamate stilbene;

3-tyrosate-5,4′-dihydroxystilbene;

5-tyrosate-3,4′-dihydroxystilbene;

4′-tyrosate-3,5-dihydroxystilbene;

3,5-dityrosate-4′-hydroxystilbene;

3,4′-dityrosate-5-hydroxystilbene;

4′,5-dityrosate-3-hydroxystilbene;

3,5,4′-trityrosate stilbene;

3-pyruvate-5,4′-dihydroxystilbene;

5-pyruvate-3,4′-dihydroxystilbene;

4′-pyruvate-3,5-dihydroxystilbene;

3,5-dipyruvate-4′-hydroxystilbene;

3,4′-dipyruvate-5-hydroxystilbene;

4′,5-dipyruvate-3-hydroxystilbene;

3,5,4′-tripyruvate stilbene;

3-acetoacetate-5,4′-dihydroxystilbene;

5-acetoacetate-3,4′-dihydroxystilbene;

4′-acetoacetate-3,5-dihydroxystilbene;

3,5-diacetoacetate-4′-hydroxystilbene;

3,4′-diacetoacetate-5-hydroxystilbene;

4′,5-diacetoacetate-3-hydroxystilbene;

3,5,4′-triacetoacetate stilbene;

3-ascorbate-5,4′-dihydroxystilbene;

5-ascorbate-3,4′-dihydroxystilbene;

4′-ascorbate-3,5-dihydroxystilbene;

3,5-diascorbate-4′-hydroxystilbene;

3,4′-diascorbate-5-hydroxystilbene;

4′,5-diascorbate-3-hydroxystilbene;

3,5,4′-triascorbate stilbene;

3-benzoate-5,4′-dihydroxystilbene;

5-benzoate-3,4′-dihydroxystilbene;

4′-benzoate-3,5-dihydroxystilbene;

3,5-dibenzoate-4′-hydroxystilbene;

3,4′-dibenzoate-5-hydroxystilbene;

4′,5-dibenzoate-3-hydroxystilbene;

3,5,4′-tribenzoate stilbene;

3-salicylate-5,4′-dihydroxystilbene;

5-salicylate-3,4′-dihydroxystilbene;

4′-salicylate-3,5-dihydroxystilbene;

3,5-disalicylate-4′-hydroxystilbene;

3,4′-disalicylate-5-hydroxystilbene;

4′,5-disalicylate-3-hydroxystilbene;

3,5,4′-trisalicylate stilbene;

3-ferulate-5,4′-dihydroxystilbene;

5-ferulate-3,4′-dihydroxystilbene;

4′-ferulate-3,5-dihydroxystilbene;

3,5-diferulate-4′-hydroxystilbene;

3,4′-diferulate-5-hydroxystilbene;

4′,5-diferulate-3-hydroxystilbene;

3,5,4′-triferulate stilbene;

3-oxalate-5,4′-dihydroxystilbene;

5-oxalate-3,4′-dihydroxystilbene;

4′-oxalate-3,5-dihydroxystilbene;

3,5-dioxalate-4′-hydroxystilbene;

3,4′-dioxalate-5-hydroxystilbene;

4′,5-dioxalate-3-hydroxystilbene;

3,5,4′-trioxalate stilbene;

3-malonate-5,4′-dihydroxystilbene;

5-malonate-3,4′-dihydroxystilbene;

4′-malonate-3,5-dihydroxystilbene;

3,5-dimalonate-4′-hydroxystilbene;

3,4′-dimalonate-5-hydroxystilbene;

4′,5-dimalonate-3-hydroxystilbene;

3,5,4′-trimalonate stilbene;

3-malate-5,4′-dihydroxystilbene;

5-malate-3,4′-dihydroxystilbene;

4′-malate-3,5-dihydroxystilbene;

3,5-dimalate-4′-hydroxystilbene;

3,4′-dimalate-5-hydroxystilbene;

4′,5-dimalate-3-hydroxystilbene;

3,5,4′-trimalate stilbene;

3-succinate-5,4′-dihydroxystilbene;

5-succinate-3,4′-dihydroxystilbene;

4′-succinate-3,5-dihydroxystilbene;

3,5-disuccinate-4′-hydroxystilbene;

3,4′-disuccinate-5-hydroxystilbene;

4′,5-disuccinate-3-hydroxystilbene;

3,5,4′-trisuccinate stilbene;

3-glutarate-5,4′-dihydroxystilbene;

5-glutarate-3,4′-dihydroxystilbene;

4′-glutarate-3,5-dihydroxystilbene;

3,5-diglutarate-4′-hydroxystilbene;

3,4′-diglutarate-5-hydroxystilbene;

4′,5-diglutarate-3-hydroxystilbene;

3,5,4′-triglutarate stilbene;

3-glutarate-5,4′-dihydroxystilbene;

5-glutarate-3,4′-dihydroxystilbene;

4′-glutarate-3,5-dihydroxystilbene;

3,5-diglutarate-4′-hydroxystilbene;

3,4′-diglutarate-5-hydroxystilbene;

4′,5-diglutarate-3-hydroxystilbene; and

3,5,4′-triglutarate stilbene;

One particularly preferred group of carboxylic acid esters ofresveratrol are either saturated or unsaturated fatty acid esters ofresveratrol, such as resveratrol butyrates, resveratrol valerates,resveratrol hexanoates, resveratrol sorbates, resveratraol laurates,resveratrol stearates, resveratrol palmitates, resveratrol oleates,resveratrol linoleates, resveratrol linolenates, resveratroleicosapentaenoates, resveratrol lipoates, and resveratroldocosahexanoates. Such fatty acid esters of resveratrol can be readilyformed by esterification of resveratrol with acid derivaties accordingto the Schotten-Baumann reaction in alkaline aqueous medium, asdescribed by U.S. Pat. No. 6,572,882, the content of which isincorporated herein by reference in its entireties for all purposes.

Another particularly preferred group of carboxylic acid esters ofresveratrol are the aromatic carboxylic acid esters of resveratrol, suchas resveratrol ferulates, which can be formed by simply combiningferulic acid with resveratrol in an aqueous medium.

C. Resveratrol Ether Derivatives

Yet another group of resveratrol derivatives that can be used in thepresent invention are resveratrol ethers, in which one or more of X, Y,and Z is —R₂, wherein R₂ is selected from the group consisting oflinear, branched or cyclic C₁-C₄₀ alkyl, substituted C₁-C₄₀ alkyl,C₁-C₄₀ alkenyl, substituted C₁-C₄₀ alkenyl, C₁-C₄₀ alkynyl, substitutedC₁-C₄₀ alkynyl, C₁-C₄₀ aryl, substituted C₁-C₄₀ aryl, and mono-, di-,oligo-, and polysaccharides. Following is a list of exemplaryresveratrol ethers that are particularly suitable for practice of thepresent invention:

3-methoxy-5,4′-dihydroxystilbene;

5-methoxy-3,4′-dihydroxystilbene;

4′-methoxy-3,5-dihydroxystilbene;

3,5-dimethoxy-4′-hydroxystilbene;

3,4′-dimethoxy-5-hydroxystilbene;

4′,5-dimethoxy-3-hydroxystilbene;

3,5,4′-trimethoxy stilbene;

3-ethoxy-5,4′-dihydroxystilbene;

5-ethoxy-3,4′-dihydroxystilbene;

4′-ethoxy-3,5-dihydroxystilbene;

3,5-diethoxy-4′-hydroxystilbene;

3,4′-diethoxy-5-hydroxystilbene;

4′,5-diethoxy-3-hydroxystilbene;

3,5,4′-triethoxy stilbene;

3-propyloxy-5,4′-dihydroxystilbene;

5-propyloxy-3,4′-dihydroxystilbene;

4′-propyloxy-3,5-dihydroxystilbene;

3,5-dipropyloxy-4′-hydroxystilbene;

3,4′-dipropyloxy-5-hydroxystilbene;

4′,5-dipropyloxy-3-hydroxystilbene;

3,5,4′-tripropyloxy stilbene;

3-phenyloxy-5,4′-dihydroxystilbene;

5-phenyloxy-3,4′-dihydroxystilbene;

4′-phenyloxy-3,5-dihydroxystilbene;

3,5-diphenyloxy-4′-hydroxystilbene;

3,4′-diphenyloxy-5-hydroxystilbene;

4′,5-diphenyloxy-3-hydroxystilbene;

3,5,4′-triphenyloxy stilbene;

3-glucoside-5,4′-dihydroxystilbene;

5-glucoside-3,4′-dihydroxystilbene;

4′-glucoside-3,5-dihydroxystilbene;

3,5-diglucoside-4′-hydroxystilbene;

3,4′-diglucoside-5-hydroxystilbene;

4′,5-diglucoside-3-hydroxystilbene; and

3,5,4′-triglucoside stilbene.

In one specific embodiment of the present invention, amethoxy-substituted resveratrol derivative is used. For example, thecompositions of the present invention may comprise3,5-dimethoxy-4′-hydroxystilbene, which can be extracted from the IndianKino Tree (Pterocarpus marsupium) and is commercially available underthe trade name “Pterostilbene” from Sigma-Aldrich at St. Louis, Mo.

In another specific embodiment of the present invention, the resveratrolderivative contains one or more saccharide-containing protective groups,such as glucose, galactose, mannose, fructose, sucrose, lactose,maltose, trehalose, and the like. For example, resveratrol glucoside,which can be obtained by extraction from plants or plant material suchas polygonum cuspidatum tissue or in vitro cultures of vitis viniferacells, is used in the cosmetic compositions of the present invention.

D. Nitrogen-Containing Derivatives of Resveratrol

The resveratrol derivatives used in the compositions of the presentinvention may also contain one or more nitrogen-containing functionalgroups, i.e., one or more of X, Y, and Z in the above formula areselected from the group consisting of amides, amines, imines, amidines,and carboxamidines. Following is a list of exemplary resveratrol ethersthat are particularly suitable for practice of the present invention:

3-amide-5,4′-dihydroxystilbene;

5-amide-3,4′-dihydroxystilbene;

4′-amide-3,5-dihydroxystilbene;

3,5-diamide-4′-hydroxystilbene;

3,4′-diamide-5-hydroxystilbene;

4′,5-diamide-3-hydroxystilbene;

3,5,4′-triamide stilbene;

3-amino-5,4′-dihydroxystilbene;

5-amino-3,4′-dihydroxystilbene;

4′-amino-3,5-dihydroxystilbene;

3,5-diamino-4′-hydroxystilbene;

3,4′-diamino-5-hydroxystilbene;

4′,5-diamino-3-hydroxystilbene;

3,5,4′-triamino stilbene;

3-imino-5,4′-dihydroxystilbene;

5-imino-3,4′-dihydroxystilbene;

4′-imino-3,5-dihydroxystilbene;

3,5-diimino-4′-hydroxystilbene;

3,4′-diimino-5-hydroxystilbene;

4′,5-diimino-3-hydroxystilbene;

3,5,4′-triimino stilbene;

3-amidino-5,4′-dihydroxystilbene;

5-amidino-3,4′-dihydroxystilbene;

4′-amidino-3,5-dihydroxystilbene;

3,5-diamidino-4′-hydroxystilbene;

3,4′-diamidino-5-hydroxystilbene;

4′,5-diamidino-3-hydroxystilbene; and

3,5,4′-triamidino stilbene.

II. Oily Phase Ingredients

The composition of the invention is in the emulsion form and comprisesan oil phase. Suitable oils include silicones, esters, vegetable oils,synthetic oils, including but not limited to those set forth herein. Theoils may be volatile or nonvolatile, and are in the form of a pourableliquid at room temperature. The term “volatile” means that the oil has ameasurable vapor pressure, or a vapor pressure of at least about 2 mm.of mercury at 20° C. The term “nonvolatile” means that the oil has avapor pressure of less than about 2 mm. of mercury at 20° C.

A. Volatile Oils

1. Volatile Silicones

Suitable volatile oils generally have a viscosity ranging from about 0.5to 5 centistokes 25° C. and include linear silicones, cyclic silicones,paraffinic hydrocarbons, or mixtures thereof.

Cyclic silicones are of the general formula:

where n=3-6.

Linear volatile silicones in accordance with the invention have thegeneral formula:(CH₃)₃Si—O—[Si(CH₃)₂—O]_(n) —Si(CH₃)₃where n=0, 1, 2, 3, 4, or 5, preferably 0, 1, 2, 3, or 4.

Linear and cyclic volatile silicones are available from variouscommercial sources including Dow Corning Corporation and GeneralElectric. The Dow Coming volatile silicones are sold under thetradenames Dow Coming 244, 245, 344, and 200 fluids. These fluidscomprise octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane,dodecamethylcyclohexasiloxane and the like. Also suitable are linearvolatile silicones such as hexamethyldisiloxane (viscosity 0.65centistokes (abbreviated cst)), octamethyltrisiloxane (1.0 cst),decamethyltetrasiloxane (1.5 cst), dodecamethylpentasiloxane (2 cst) andmixtures thereof.

2. Volatile Paraffinic Hydrocarbons

Also suitable as the volatile oils are various straight or branchedchain paraffinic hydrocarbons having 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,15, 16, 17, 18, 19, or 20 carbon atoms, more preferably 8 to 16 carbonatoms. Suitable hydrocarbons include pentane, hexane, heptane, decane,dodecane, tetradecane, tridecane, and C₈₋₂₀ isoparaffins as disclosed inU.S. Pat. Nos. 3,439,088 and 3,818,105, both of which are herebyincorporated by reference in their entireties for all purposes.

Preferred volatile paraffinic hydrocarbons have a molecular weight of70-225, preferably 160 to 190 and a boiling point range of 30 to 320,preferably 60 to 260° C., and a viscosity of less than about 10 cst. at25° C. Such paraffinic hydrocarbons are available from EXXON under theISOPARS trademark, and from the Permethyl Corporation. Suitable C₁₂isoparaffins are manufactured by Permethyl Corporation under thetradename Permethyl 99A. Various C₁₆ isoparaffins commerciallyavailable, such as isohexadecane (having the tradename Permethyl R), arealso suitable.

B. Non-Volatile Oils

A variety of nonvolatile oils are also suitable for use in the cosmeticcompositions of the invention. The nonvolatile oils generally have aviscosity of greater than about 5 to 10 centistokes at 25° C., and mayrange in viscosity up to about 1,000,000 centipoise at 25° C. Examplesof nonvolatile oils include, but are not limited to:

1. Esters

Suitable esters are mono-, di-, and triesters. The composition maycomprise one or more esters selected from the group, or mixturesthereof.

(a) Monoesters

Monoesters are defined as esters formed by the reaction of amonocarboxylic acid having the formula R—COOH, wherein R is a straightor branched chain saturated or unsaturated alkyl having 2 to 45 carbonatoms, or phenyl; and an alcohol having the formula R—OH wherein R is astraight or branched chain saturated or unsaturated alkyl having 2-30carbon atoms, or phenyl. Both the alcohol and the acid may besubstituted with one or more hydroxyl groups. Either one or both of theacid or alcohol may be a “fatty” acid or alcohol, and may have fromabout 6 to 30 carbon atoms, more preferably 12, 14, 16, 18, or 22 carbonatoms in straight or branched chain, saturated or unsaturated form.Examples of monoester oils that may be used in the compositions of theinvention include hexyl laurate, butyl isostearate, hexadecylisostearate, cetyl palmitate, isostearyl neopentanoate, stearylheptanoate, isostearyl isononanoate, steary lactate, stearyl octanoate,stearyl stearate, isononyl isononanoate, and so on.

(b). Diesters

Suitable diesters are the reaction product of a dicarboxylic acid and analiphatic or aromatic alcohol or an aliphatic or aromatic alcohol havingat least two substituted hydroxyl groups and a monocarboxylic acid. Thedicarboxylic acid may contain from 2 to 30 carbon atoms, and may be inthe straight or branched chain, saturated or unsaturated form. Thedicarboxylic acid may be substituted with one or more hydroxyl groups.The aliphatic or aromatic alcohol may also contain 2 to 30 carbon atoms,and may be in the straight or branched chain, saturated, or unsaturatedform. Preferably, one or more of the acid or alcohol is a fatty acid oralcohol, i.e. contains 12-22 carbon atoms. The dicarboxylic acid mayalso be an alpha hydroxy acid. The ester may be in the dimer or trimerform. Examples of diester oils that may be used in the compositions ofthe invention include diisotearyl malate, neopentyl glycol dioctanoate,dibutyl sebacate, dicetearyl dimer dilinoleate, dicetyl adipate,diisocetyl adipate, diisononyl adipate, diisostearyl dimer dilinoleate,diisostearyl fumarate, diisostearyl malate, dioctyl malate, and so on.

(c). Triesters

Suitable triesters comprise the reaction product of a tricarboxylic acidand an aliphatic or aromatic alcohol or alternatively the reactionproduct of an aliphatic or aromatic alcohol having three or moresubstituted hydroxyl groups with a monocarboxylic acid. As with themono- and diesters mentioned above, the acid and alcohol contain 2 to 30carbon atoms, and may be saturated or unsaturated, straight or branchedchain, and may be substituted with one or more hydroxyl groups.Preferably, one or more of the acid or alcohol is a fatty acid oralcohol containing 12 to 22 carbon atoms. Examples of triesters includeesters of arachidonic, citric, or behenic acids, such as triarachidin,tributyl citrate, triisostearyl citrate, tri C₁₂₋₁₃ alkyl citrate,tricaprylin, tricaprylyl citrate, tridecyl behenate, trioctyldodecylcitrate, tridecyl behenate; or tridecyl cocoate, tridecyl isononanoate,and so on.

Esters suitable for use in the composition are further described onpages 1670-1676 of the C.T.F.A. Cosmetic Ingredient Dictionary andHandbook, Eighth Edition, 2000, which is hereby incorporated byreference in its entirety.

2. Hydrocarbon Oils

It may be desirable to incorporate one or more nonvolatile hydrocarbonoils into the composition. Suitable nonvolatile hydrocarbon oils includeparaffinic hydrocarbons and olefins, preferably those having greaterthan about 20 carbon atoms. Examples of such hydrocarbon oils includeC₂₄₋₂₈ olefins, C₃₀₋₄₅ olefins, C₂₀₋₄₀ isoparaffins, hydrogenatedpolyisobutene, polyisobutene, polydecene, hydrogenated polydecene,mineral oil, pentahydrosqualene, squalene, squalane, and mixturesthereof. In one preferred embodiment such hydrocarbons have a molecularweight ranging from about 300 to 1000 Daltons.

3. Glyceryl Esters of Fatty Acids

Synthetic or naturally occurring glyceryl esters of fatty acids, ortriglycerides, are also suitable for use in the compositions. Bothvegetable and animal sources may be used. Examples of such oils includecastor oil, lanolin oil, C₁₀₋₁₈ triglycerides,caprylic/capric/triglycerides, sweet almond oil, apricot kernel oil,sesame oil, camelina sativa oil, tamanu seed oil, coconut oil, corn oil,cottonseed oil, linseed oil, ink oil, olive oil, palm oil, illipebutter, rapeseed oil, soybean oil, grapeseed oil, sunflower seed oil,walnut oil, and the like.

Also suitable are synthetic or semi-synthetic glyceryl esters, such asfatty acid mono-, di-, and triglycerides which are natural fats or oilsthat have been modified, for example, mono-, di- or triesters of polyolssuch as glycerin. In an example, a fatty (C₁₂₋₂₂) carboxylic acid isreacted with one or more repeating glyceryl groups. glyceryl stearate,diglyceryl diiosostearate, polyglyceryl-3 isostearate, polyglyceryl-4isostearate, polyglyceryl-6 ricinoleate, glyceryl dioleate, glyceryldiisotearate, glyceryl tetraisostearate, glyceryl trioctanoate,diglyceryl distearate, glyceryl linoleate, glyceryl myristate, glycerylisostearate, PEG castor oils, PEG glyceryl oleates, PEG glycerylstearates, PEG glyceryl tallowates, and so on.

4. Nonvolatile Silicones

Nonvolatile silicone oils, both water soluble and water insoluble, arealso suitable for use in the composition. Such silicones preferably havea viscosity ranging from about 10 to 800,000 cst, preferably 20 to200,000 cst at 25° C. Suitable water insoluble silicones include aminefunctional silicones such as amodimethicone; phenyl substitutedsilicones such as bisphenylhexamethicone, trimethylsiloxyphenyldimethicone, phenyl trimethicone, or polyphenylmethylsiloxane;dimethicone, dimethicone substituted with C₂₋₃₀ alkyl groups such cetyldimethicone.

Nonvolatile silicones may have the following general formula:

wherein R and R′ are each independently C₁₋₃₀ straight or branchedchain, saturated or unsaturated alkyl, phenyl or aryl, trialkylsiloxy,and x and y are each independently 0-1,000,000; with the proviso thatthere is at least one of either x or y, and A is alkyl siloxy endcapunit. Preferred is where A is a methyl siloxy endcap unit; in particulartrimethylsiloxy, and R and R′ are each independently a C₁₋₃₀ straight orbranched chain alkyl, phenyl, or trimethylsiloxy, more preferably aC₁₋₂₂ alkyl, phenyl, or trimethylsiloxy, most preferably methyl, phenyl,or trimethylsiloxy, and resulting silicone is dimethicone, phenyldimethicone, diphenyl dimethicone, phenyl trimethicone, ortrimethylsiloxyphenyl dimethicone. Other examples include alkyldimethicones such as cetyl dimethicone, and the like wherein at leastone R is a fatty alkyl (C₁₂, C₁₄, C₁₆, C₁₈, C₂₀, or C₂₂), and the otherR is methyl, and A is a trimethylsiloxy endcap unit, provided such alkyldimethicone is a pourable liquid at room temperature. Phenyltrimethicone can be purchased from Dow Corning Corporation under thetradename 556 Fluid. Trimethylsiloxyphenyl dimethicone can be purchasedfrom Wacker-Chemie under the tradename PDM-1000. Cetyl dimethicone, alsoreferred to as a liquid silicone wax, may be purchased from Dow Corningas Fluid 2502, or from DeGussa Care & Surface Specialties under thetradenames Abil Wax 9801, or 9814.

5. Fluorinated Oils

Various types of fluorinated oils may also be suitable for use in thecompositions including but not limited to fluorinated silicones,fluorinated esters, or perfluropolyethers. Particularly suitable arefluorosilicones such as trimethylsilyl endcapped fluorosilicone oil,polytrifluoropropylmethylsiloxanes, and similar silicones such as thosedisclosed in U.S. Pat. No. 5,118,496 which is hereby incorporated byreference. Perfluoropolyethers include those disclosed in U.S. Pat. Nos.5,183,589, 4,803,067, 5,183,588 all of which are hereby incorporated byreference, which are commercially available from Montefluos under thetrademark Fomblin.

III. Silicone Surfactants

The composition of the invention comprises at least one siliconesurfactant, which includes polyorganosiloxane polymers that haveamphiphilic properties, for example contain both hydrophilic radicalsand lipophilic radicals. These silicone surfactants may be liquids orsolids at room temperature. Suggested ranges of silicone surfactants arefrom about 0.01 to 50%, preferably from about 0.05 to 40%, morepreferably from about 0.1 to 35% by weight of the total composition.

A. Dimethicone Copolyols or Alkyl Dimethicone Copolyols

One type of silicone surfactant that may be used is generally referredto as dimethicone copolyol or alkyl dimethicone copolyol. Thissurfactant is either a water-in-oil or oil-in-water surfactant having anHydrophile/Lipophile Balance (HLB) ranging from about 2 to 18.Preferably the silicone surfactant is a nonionic surfactant having anHLB ranging from about 2 to 12, preferably about 2 to 10, mostpreferably about 4 to 6. The term “hydrophilic radical” means a radicalthat, when substituted onto the organosiloxane polymer backbone, confershydrophilic properties to the substituted portion of the polymer.Examples of radicals that will confer hydrophilicity arehydroxy-polyethyleneoxy, hydroxyl, carboxylates, and mixtures thereof.The term “lipophilic radical” means an organic radical that, whensubstituted onto the organosiloxane polymer backbone, confers lipophilicproperties to the substituted portion of the polymer. Examples oforganic radicals that will confer lipophilicity are C₁₋₄₀ straight orbranched chain alkyl, fluoro, aryl, aryloxy, C₁₋₄₀ hydrocarbyl acyl,hydroxy-polypropyleneoxy, or mixtures thereof.

One type of suitable silicone surfactant has the general formula:

wherein p and q are from 0 to 40 (the range including all numbersbetween and subranges such as 2, 3, 4, 13, 14, 15, 16, 17, 18, etc.),and PE is (—C₂H₄O)_(a)—(—C₃H₆O)_(b)—H, wherein a is from 0 to 25, b isfrom 0 to 25, with the proviso that a and b cannot both be 0simultaneously, wherein x, y and z are each independently ranging from 0to 1 million, with the proviso that they cannot all be 0 simultaneously.In one preferred embodiment, x, y, z, a, and b are such that themolecular weight of the polymer ranges from about 5,000 to about500,000, more preferably from about 10,000 to 100,000, and is mostpreferably approximately about 50,000 and the polymer is genericallyreferred to as dimethicone copolyol.

One type of silicone surfactant is wherein p is such that the long chainalkyl is a C₁₀₋₂₂ straight or branched chain alkyl, more preferably aC₁₀₋₁₈ fatty alkyl such as cetyl or lauryl, and the surfactant iscalled, generically, cetyl dimethicone copolyol or lauryl dimethiconecopolyol respectively.

In some cases the number of repeating ethylene oxide or propylene oxideunits in the polymer are also specified, such as a dimethicone copolyolthat is also referred to as PEG-15/PPG-10 dimethicone, which refers to adimethicone having substituents containing 15 ethylene glycol units and10 propylene glycol units on the siloxane backbone. It is also possiblefor one or more of the methyl groups in the above general structure tobe substituted with a longer chain alkyl (e.g. ethyl, propyl, butyl,etc.) or an ether such as methyl ether, ethyl ether, propyl ether, butylether, and the like.

Examples of silicone surfactants are those sold by Dow Corning under thetradename Dow Corning 3225C Formulation Aid having the CTFA namecyclotetrasiloxane (and) cyclopentasiloxane (and) PEG/PPG-18dimethicone; or 5225C Formulation Aid, having the CTFA namecyclopentasiloxane (and) PEG/PPG-18/18 dimethicone; or Dow Coming 190Surfactant having the CTFA name PEG/PPG-18/18 dimethicone; or DowCorning 193 Fluid, Dow Corning 5200 having the CTFA name laurylPEG/PPG-18/18 methicone; or Abil EM 90 having the CTFA name cetylPEG/PPG-14/14 dimethicone sold by Goldschmidt; or Abil EM 97 having theCTFA name bis-cetyl PEG/PPG-14/14 dimethicone sold by Goldschmidt; orAbil WE 09 having the CTFA name cetyl PEG/PPG-10/1 dimethicone in amixture also containing polyglyceryl-4 isostearate and hexyl laurate; orKF-6011 sold by Shin-Etsu Silicones having the CTFA name PEG-11 methylether dimethicone; KF-6012 sold by Shin-Etsu Silicones having the CTFAname PEG/PPG-20/22 butyl ether dimethicone; or KF-6013 sold by Shin-EtsuSilicones having the CTFA name PEG-9 dimethicone; or KF-6015 sold byShin-Etsu Silicones having the CTFA name PEG-3 dimethicone; or KF-6016sold by Shin-Etsu Silicones having the CTFA name PEG-9 methyl etherdimethicone; or KF-6017 sold by Shin-Etsu Silicones having the CTFA namePEG-10 dimethicone; or KF-6038 sold by Shin-Etsu Silicones having theCTFA name lauryl PEG-9 polydimethylsiloxyethyl dimethicone.

B. Crosslinked Silicone Surfactants

Also suitable are various types of crosslinked silicone surfactants arereferred to as emulsifying elastomers. They are typically prepared asset forth above with respect to the section “silicone elastomers” exceptthat the silicone elastomers will contain at least one hydrophilicmoiety such as polyoxyalkylenated groups. Typically thesepolyoxyalkylenated silicone elastomers are crosslinkedorganopolysiloxanes that may be obtained by a crosslinking additionreaction of diorganopolysiloxane comprising at least one hydrogen bondedto silicon and of a polyoxyalkylene comprising at least twoethylenically unsaturated groups. In at least one embodiment, thepolyoxyalkylenated crosslinked organo-polysiloxanes are obtained by acrosslinking addition reaction of a diorganopolysiloxane comprising atleast two hydrogens each bonded to a silicon, and a polyoxyalkylenecomprising at least two ethylenically unsaturated groups, optionally inthe presence of a platinum catalyst, as described, for example, in U.S.Pat. No. 5,236,986 and U.S. Pat. No. 5,412,004, U.S. Pat. No. 5,837,793and U.S. Pat. No. 5,811,487, the contents of which are incorporated byreference.

Polyoxyalkylenated silicone elastomers that may be used in at least oneembodiment of the invention include those sold by Shin-Etsu Siliconesunder the names KSG-21, KSG-20, KSG-30, KSG-31, KSG-32, KSG-33; KSG-210which is dimethicone/PEG-10/15 crosspolymer dispersed in dimethicone;KSG-310 which is PEG-15 lauryl dimethicone crosspolymer; KSG-320 whichis PEG-15 lauryl dimethicone crosspolymer dispersed in isododecane;KSG-330 (the former dispersed in triethylhexanoin), KSG-340 which is amixture of PEG-10 lauryl dimethicone crosspolymer and PEG-15 lauryldimethicone crosspolymer.

Also suitable are polyglycerolated silicone elastomers like thosedisclosed in PCT/WO 2004/024798, which is hereby incorporated byreference in its entirety. Such elastomers include Shin-Etsu's KSGseries, such as KSG-710 which is dimethicone/polyglycerin-3 crosspolymerdispersed in dimethicone; or lauryl dimethicone/polyglycerin-3crosspolymer dispersed in a variety of solvent such as isododecane,dimethicone, triethylhexanoin, sold under the Shin-Etsu tradenamesKSG-810, KSG-820, KSG-830, or KSG-840. Also suitable are silicones soldby Dow Corning under the tradenames 9010 and DC9011.

One preferred crosslinked silicone elastomer emulsifier isdimethicone/PEG-10/15 crosspolymer.

IV. Other Ingredients

The compositions of the invention may contain a variety of otheringredients including, but not limited to, additional surfactants,structuring agents, botanicals, sugars, humectants, preservatives,peptides, and the like, including but not limited to those mentionedherein.

A. Additional Surfactants

The composition preferably contains one or more additional surfactants,such as nonionic organic surfactants. If present, suggested ranges arefrom about 0.01 to 40%, preferably from about 0.05 to 35%, morepreferably from about 0.1 to 30% by weight of the total composition.Suitable nonionic surfactants include alkoxylated alcohols, or ethers,formed by the reaction of an alcohol with an alkylene oxide, usuallyethylene or propylene oxide. Preferably the alcohol is either a fattyalcohol having 6 to 30 carbon atoms Examples of such ingredients includeSteareth 2-100, which is formed by the reaction of stearyl alcohol andethylene oxide and the number of ethylene oxide units ranges from 2 to100; Beheneth 5-30 which is formed by the reaction of behenyl alcoholand ethylene oxide where the number of repeating ethylene oxide units is5 to 30; Ceteareth 2-100, formed by the reaction of a mixture of cetyland stearyl alcohol with ethylene oxide, where the number of repeatingethylene oxide units in the molecule is 2 to 100; Ceteth 1-45 which isformed by the reaction of cetyl alcohol and ethylene oxide, and thenumber of repeating ethylene oxide units is 1 to 45, and so on.

Other alkoxylated alcohols are formed by the reaction of fatty acids andmono-, di- or polyhydric alcohols with an alkylene oxide. For example,the reaction products of C₆₋₃₀ fatty carboxylic acids and polyhydricalcohols which are monosaccharides such as glucose, galactose, methylglucose, and the like, with an alkoxylated alcohol. Examples includepolymeric alkylene glycols reacted with glyceryl fatty acid esters suchas PEG glyceryl oleates, PEG glyceryl stearate; or PEGpolyhydroxyalkanotes such as PEG dipolyhydroxystearate wherein thenumber of repeating ethylene glycol units ranges from 3 to 1000.

Also suitable as nonionic surfactants are formed by the reaction of acarboxylic acid with an alkylene oxide or with a polymeric ether. Theresulting products have the general formula: where RCO is the carboxylicester radical, X is hydrogen or lower alkyl, and n is the number ofpolymerized alkoxy groups. In the case of the diesters, the twoRCO-groups do not need to be identical. Preferably, R is a C₆₋₃₀straight or branched chain, saturated or unsaturated alkyl, and n isfrom 1-100.

Monomeric, homopolymeric, or block copolymeric ethers are also suitableas nonionic surfactants. Typically, such ethers are formed by thepolymerization of monomeric alkylene oxides, generally ethylene orpropylene oxide. Such polymeric ethers have the following generalformula: wherein R is H or lower alkyl and n is the number of repeatingmonomer units, and ranges from 1 to 500.

Other suitable nonionic surfactants include alkoxylated sorbitan andalkoxylated sorbitan derivatives. For example, alkoxylation, inparticular ethoxylation of sorbitan provides polyalkoxylated sorbitanderivatives. Esterification of polyalkoxylated sorbitan providessorbitan esters such as the polysorbates. For example, thepolyalkyoxylated sorbitan can be esterified with C₆₋₃₀, preferablyC₁₂₋₂₂ fatty acids. Examples of such ingredients include Polysorbates20-85, sorbitan oleate, sorbitan sesquioleate, sorbitan palmitate,sorbitan sesquiisostearate, sorbitan stearate, and so on.

Certain types of amphoteric, zwitterionic, or cationic surfactants mayalso be used in the compositions. Descriptions of such surfactants areset forth in U.S. Pat. No. 5,843,193, which is hereby incorporated byreference in its entirety.

B. Oil Phase Structuring Agents

A variety of oil phase structuring agents may be present. The term “oilphase structuring agent” means an ingredient or combination ofingredients, soluble or dispersible in the oil phase, which willincrease the viscosity, or structure, the oil phase. The oil phasestructuring agent is compatible with the resveratrol derivative and therest of the formulation ingredients. The term “compatible” means thatthe oil phase structuring agent and resveratrol derivative are capableof being formulated into a cosmetic product that is generally stable.The structuring agent may be present in an amount sufficient to providea liquid composition with increased viscosity, a semi-solid, or in somecases a solid composition that may be self-supporting. The structuringagent itself may be present in the liquid, semi-solid, or solid form.Suggested ranges of structuring agent are from about 0.01 to 70%,preferably from about 0.05 to 50%, more preferably from about 0.1-35% byweight of the total composition. Suitable oil phase structuring agentsinclude those that are silicone based or organic based. They may bepolymers or non-polymers, synthetic, natural, or a combination of both.

1. Silicone Structuring Agents

A variety of oil phase structuring agents may be silicone based, such assilicone elastomers, silicone gums, silicone waxes, linear siliconeshaving a degree of polymerization that provides the silicone with adegree of viscosity such that when incorporated into the cosmeticcomposition it is capable of increasing the viscosity of the oil phase.Examples of silicone structuring agents include, but are not limited to:

(a). Silicone Elastomers

Silicone elastomers suitable for use in the compositions of theinvention include those that are formed by addition reaction-curing, byreacting an SiH-containing diorganosiloxane and an organopolysiloxanehaving terminal olefinic unsaturation, or an alpha-omega dienehydrocarbon, in the presence of a platinum metal catalyst. Suchelastomers may also be formed by other reaction methods such ascondensation-curing organopolysiloxane compositions in the presence ofan organotin compound via a dehydrogenation reaction betweenhydroxyl-terminated diorganopolysiloxane and SiH-containingdiorganopolysiloxane or alpha omega diene; or by condensation-curingorganopolysiloxane compositions in the presence of an organotin compoundor a titanate ester using a condensation reaction between anhydroxyl-terminated diorganopolysiloxane and a hydrolysableorganosiloxane; peroxide-curing organopolysiloxane compositions whichthermally cure in the presence of an organoperoxide catalyst.

One type of elastomer that may be suitable is prepared by additionreaction-curing an organopolysiloxane having at least 2 lower alkenylgroups in each molecule or an alpha-omega diene; and anorganopolysiloxane having at least 2 silicon-bonded hydrogen atoms ineach molecule; and a platinum-type catalyst. While the lower alkenylgroups such as vinyl, can be present at any position in the molecule,terminal olefinic unsaturation on one or both molecular terminals ispreferred. The molecular structure of this component may be straightchain, branched straight chain, cyclic, or network. Theseorganopolysiloxanes are exemplified by methylvinylsiloxanes,methylvinylsiloxane-dimethylsiloxane copolymers,dimethylvinylsiloxy-terminated dimethylpolysiloxanes,dimethylvinylsiloxy-terminated dimethylsiloxane-methylphenylsiloxanecopolymers, dimethylvinylsiloxy-terminateddimethylsiloxane-diphenylsiloxane-methylvinylsiloxane copolymers,trimethylsiloxy-terminated dimethylsiloxane-methylvinylsiloxanecopolymers, trimethylsiloxy-terminateddimethylsiloxane-methylphenylsiloxane-methylvinylsiloxane copolymers,dimethylvinylsiloxy-terminatedmethyl(3,3,3-trifluoropropyl)polysiloxanes, anddimethylvinylsiloxy-terminateddimethylsiloxane-methyl(3,3,-trifluoropropyl)siloxane copolymers,decadiene, octadiene, heptadiene, hexadiene, pentadiene, or tetradiene,or tridiene.

Curing proceeds by the addition reaction of the silicon-bonded hydrogenatoms in the dimethyl methylhydrogen siloxane, with the siloxane oralpha-omega diene under catalysis using the catalyst mentioned herein.To form a highly crosslinked structure, the methyl hydrogen siloxanemust contain at least 2 silicon-bonded hydrogen atoms in each moleculein order to optimize function as a crosslinker.

The catalyst used in the addition reaction of silicon-bonded hydrogenatoms and alkenyl groups, and is concretely exemplified bychloroplatinic acid, possibly dissolved in an alcohol or ketone and thissolution optionally aged, chloroplatinic acid-olefin complexes,chloroplatinic acid-alkenylsiloxane complexes, chloroplatinicacid-diketone complexes, platinum black, and carrier-supported platinum.

Examples of suitable silicone elastomers for use in the compositions ofthe invention may be in the powder form, or dispersed or solubilized insolvents such as volatile or non-volatile silicones, or siliconecompatible vehicles such as paraffinic hydrocarbons or esters. Examplesof silicone elastomer powders include vinyl dimethicones/methiconesilesquioxane crosspolymers like Shin-Etsu's KSP-100, KSP-101, KSP-102,KSP-103, KSP-104, KSP-105, hybrid silicone powders that contain afluoroalkyl group like Shin-Etsu's KSP-200 which is a fluoro-siliconeelastomer, and hybrid silicone powders that contain a phenyl group suchas Shin-Etsu's KSP-300, which is a phenyl substituted siliconeelastomer; and Dow Coming's DC 9506. Examples of silicone elastomerpowders dispersed in a silicone compatible vehicle includedimethicones/vinyl dimethicones crosspolymers supplied by a variety ofsuppliers including Dow Coming Corporation under the tradenames 9040 or9041, GE Silicones under the tradename SFE 839, or Shin-Etsu Siliconesunder the tradenames KSG-15, 16, 18. KSG-15 has the CTFA namecyclopentasiloxane/dimethicones/vinyl dimethicones crosspolymer. KSG-18has the INCI name phenyl trimethicone/dimethicones/phenyl vinyldimethicones dimethicones. Silicone elastomers may also be purchasedfrom Grant Industries under the Gransil trademark. Also suitable aresilicone elastomers having long chain alkyl substitutions such as lauryldimethicones/vinyl dimethicones crosspolymers supplied by Shin Etsuunder the tradenames KSG-31, KSG-32, KSG-41, KSG-42, KSG-43, and KSG-44.Cross-linked organopolysiloxane elastomers useful in the presentinvention and processes for making them are further described in U.S.Pat. No. 4,970,252 to Sakuta et al., issued Nov. 13, 1990; U.S. Pat. No.5,760,116 to Kilgour et al., issued Jun. 2, 1998; U.S. Pat. No.5,654,362 to Schulz, Jr. et al. issued Aug. 5, 1997; and Japanese PatentApplication JP 61-18708, assigned to Pola Kasei Kogyo KK, each of whichare herein incorporated by reference in its entirety.

(b). Silicone Gums

Also suitable for use as an oil phase structuring agent are one or moresilicone gums. The term “gum” means a silicone polymer having a degreeof polymerization sufficient to provide a silicone having a gum-liketexture. In certain cases the silicone polymer forming the gum may becrosslinked. The silicone gum typically has a viscosity ranging fromabout 500,000 to 100 million cst at 25° C., preferably from about600,000 to 20 million, more preferably from about 600,000 to 12 millioncst. All ranges mentioned herein include all subranges, e.g. 550,000;925,000; 3.5 million.

The silicone gums that are used in the compositions include, but are notlimited to, those of the general formula wherein:

R₁ to R₉ are each independently an alkyl having 1 to 30 carbon atoms,aryl, or aralkyl; and X is OH or a C₁₋₃₀ alkyl, or vinyl; and wherein x,y, or z may be zero with the proviso that no more than two of x, y, or zare zero at any one time, and further that x, y, and z are such that thesilicone gum has a viscosity of at least about 500,000 cst, ranging upto about 100 million centistokes at 25° C. Preferred is where R ismethyl or OH.

Such silicone gums may be purchased in pure form from a variety ofsilicone manufacturers including Wacker-Chemie or Dow Coming, and thelike. Such silicone gums include those sold by Wacker-Belsil under thetrade names CM3092, Wacker-Belsil 1000, or Wacker-Belsil DM 3096. Asilicone gum where X is OH, also referred to as dimethiconol, isavailable from Dow Coming Corporation under the trade name 1401. Thesilicone gum may also be purchased in the form of a solution ordispersion in a silicone compatible vehicle such as volatile ornonvolatile silicone. An example of such a mixture may be purchased fromBamet Silicones under the HL-88 tradename, having the INCI namedimethicone.

(c). Silicone Waxes

Another type of oily phase structuring agent includes silicone waxesthat are typically referred to as alkyl silicone waxes which aresemi-solids or solids at room temperature. The term “alkyl silicone wax”means a polydimethylsiloxane having a substituted long chain alkyl (suchas C16 to 30) that confers a semi-solid or solid property to thesiloxane. Examples of such silicone waxes include stearyl dimethicone,which may be purchased from DeGussa Care & Surface Specialties under thetradename Abil Wax 9800 or from Dow Coming under the tradename 2503.Another example is bis-stearyl dimethicone, which may be purchased fromGransil Industries under the tradename Gransil A-18, or behenyldimethicone, behenoxy dimethicone.

(d). Polyamides or Silicone Polyamides

Also suitable as oil phase structuring agents are various types ofpolymeric compounds such as polyamides or silicone polyamides.

The term silicone polyamide means a polymer comprised of siliconemonomers and monomers containing amide groups as further describedherein. The silicone polyamide preferably comprises moieties of thegeneral formula:

X is a linear or branched alkylene having from about 1-30 carbon atoms;

R₁, R₂, R₃, and R₄ are each independently C₁₋₃₀ straight or branchedchain alkyl which may be substituted with one or more hydroxyl orhalogen groups; phenyl which may be substituted with one or more C₁₋₃₀alkyl groups, halogen, hydroxyl, or alkoxy groups; or a siloxane chainhaving the general formula:

and Y is:

(a) a linear or branched alkylene having from about 1-40 carbon atomswhich may be substituted with (i) one or more amide groups having thegeneral formula R₁CONR₁, or (ii) C₅₋₆ cyclic ring, or (iii) phenylenewhich may be substituted with one or more C₁₋₁₀ alkyl groups, or (iv)hydroxy, or (v) C₃₋₈ cycloalkane, or (vi) C₁₋₂₀ alkyl which may besubstituted with one or more hydroxy groups, or (vii) C₁₋₁₀ alkylamines; or

(b) TR₅R₆R₇

wherein R₅, R₆, and R₇, are each independently a C₁₋₁₀ linear orbranched alkylenes, and T is CR₈ wherein R₈ is hydrogen, a trivalentatom N, P, or Al, or a C₁₋₃₀ straight or branched chain alkyl which maybe substituted with one or more hydroxyl or halogen groups; phenyl whichmay be substituted with one or more C₁₋₃₀ alkyl groups, halogen,hydroxyl, or alkoxy groups; or a siloxane chain having the generalformula:

Preferred is where R₁, R₂, R₃, and R₄ are C₁₋₁₀, preferably methyl; andX and Y is a linear or branched alkylene. Preferred are siliconepolyamides having the general formula

wherein a and b are each independently sufficient to provide a siliconepolyamide polymer having a melting point ranging from about 60 to 120°C., and a molecular weight ranging from about 40,000 to 500,000 Daltons.One type of silicone polyamide that may be used in the compositions ofthe invention may be purchased from Dow Coming Corporation under thetradename Dow Coming 2-8178 gellant which has the CTFA namenylon-611/dimethicone copolymer which is sold in a compositioncontaining PPG-3 myristyl ether.

Also suitable are polyamides such as those purchased from ArizonaChemical under the tradenames Uniclear and Sylvaclear. Such polyamidesmay be ester terminated or amide terminated. Examples of esterterminated polyamides include, but are not limited to those having thegeneral formula:

wherein n denotes a number of amide units such that the number of estergroups ranges from about 10% to 50% of the total number of ester andamide groups; each R₁ is independently an alkyl or alkenyl groupcontaining at least 4 carbon atoms; each R₂ is independently a C₄₋₄₂hydrocarbon group, with the proviso that at least 50% of the R₂ groupsare a C30-42 hydrocarbon; each R₃ is independently an organic groupcontaining at least 2 carbon atoms, hydrogen atoms and optionally one ormore oxygen or nitrogen atoms; and each R₄ is independently a hydrogenatom, a C₁₋₁₀ alkyl group or a direct bond to R₃ or to another R₄, suchthat the nitrogen atom to which R₃ and R₄ are both attached forms partof a heterocyclic structure defined by R₄—N—R₃, with at least 50% of thegroups R₄ representing a hydrogen atom.

General examples of ester and amide terminated polyamides that may beused as oil phase gelling agents include those sold by Arizona Chemicalunder the tradenames Sylvaclear A200V or A2614V, both having the CTFAname ethylenediamine/hydrogenated dimer dilinoleatecopolymer/bis-di-C₁₄₋₁₈ alkyl amide; Sylvaclear AF1900V; Sylvaclear C75Vhaving the CTFA name bis-stearyl ethylenediamine/neopentylglycol/stearyl hydrogenated dimer dilinoleate copolymer; SylvaclearPA1200V having the CTFA name Polyamide-3; Sylvaclear PE400V; SylvaclearWF1500V; or Uniclear, such as Uniclear 100VG having the INCI nameethylenediamine/stearyl dimer dilinoleate copolymer; orethylenediamine/stearyl dimer ditallate copolymer. Other examples ofsuitable polyamides include those sold by Henkel under the Versamidtrademark (such as Versamid 930, 744, 1655), or by Olin MathiesonChemical Corp. under the brand name Onamid S or Onamid C.

2. Natural or Synthetic Organic Waxes

Also suitable as the oil phase structuring agent may be one or morenatural or synthetic waxes such as animal, vegetable, or mineral waxes.Preferably such waxes will have a higher melting point such as fromabout 60 to 150° C., more preferably from about 65 to 100° C. Examplesof such waxes include waxes made by Fischer-Tropsch synthesis, such aspolyethylene or synthetic wax; or various vegetable waxes such asbayberry, candelilla, ozokerite, acacia, beeswax, ceresin, cetyl esters,flower wax, citrus wax, carnauba wax, jojoba wax, japan wax,polyethylene, microcrystalline, rice bran, lanolin wax, mink, montan,bayberry, ouricury, ozokerite, palm kernel wax, paraffin, avocado wax,apple wax, shellac wax, clary wax, spent grain wax, grape wax, andpolyalkylene glycol derivatives thereof such as PEG6-20 beeswax, orPEG-12 carnauba wax; or fatty acids or fatty alcohols, including estersthereof, such as hydroxystearic acids (for example 12-hydroxy stearicacid), tristearin, tribehenin, and so on.

3. Montmorillonite Minerals

One type of structuring agent that may be used in the compositioncomprises natural or synthetic montmorillonite minerals such ashectorite, bentonite, and quaternized derivatives thereof, which areobtained by reacting the minerals with a quaternary ammonium compound,such as stearalkonium bentonite, hectorites, quaternized hectorites suchas Quaternium-18 hectorite, attapulgite, carbonates such as propylenecarbonate, bentones, and the like.

4. Silicas and Silicates

Another type of structuring agent that may be used in the compositionsare silicas, silicates, silica silylate, and alkali metal or alkalineearth metal derivatives thereof. These silicas and silicates aregenerally found in the particulate form and include silica, silicasilylate, magnesium aluminum silicate, and the like.

C. Humectants

It may also be desirable to include one or more humectants in thecomposition. If present, such humectants may range from about 0.001 to25%, preferably from about 0.005 to 20%, more preferably from about 0.1to 15% by weight of the total composition. Examples of suitablehumectants include glycols, sugars, and the like. Suitable glycols arein monomeric or polymeric form and include polyethylene andpolypropylene glycols such as PEG 4-200, which are polyethylene glycolshaving from 4 to 200 repeating ethylene oxide units; as well as C₁₋₆alkylene glycols such as propylene glycol, butylene glycol, pentyleneglycol, and the like. Suitable sugars, some of which are also polyhydricalcohols, are also suitable humectants. Examples of such sugars includeglucose, fructose, honey, hydrogenated honey, inositol, maltose,mannitol, maltitol, sorbitol, sucrose, xylitol, xylose, and so on.Preferably, the humectants used in the composition of the invention areC₁₋₆, preferably C₂₋₄ alkylene glycols, most particularly butyleneglycol.

D. Aqueous Phase Structuring Agents

It may be desirable to include one or more aqueous phase structuringagents in the composition. Such agents will typically thicken orincrease the viscosity of the aqueous phase of the emulsion. If present,suggested ranges are from about 0.01 to 30%, preferably from about 0.1to 20%, more preferably from about 0.5 to 15% by weight of the totalcomposition. Examples of such agents include various acrylate basedthickening agents, natural or synthetic gums, polysaccharides, and thelike.

1. Polysaccharides

A variety of polysaccharides in various forms may be suitable aqueousphase thickening agents. Examples of such polysaccharides includenaturally derived materials such as agar, agarose, alicaligenespolysaccharides, algin, alginic acid, amylopectin, chitin, dextran,cassia gum, cellulose gum, gelatin, gellan gum, hyaluronic acid,hydroxyethyl cellulose, methyl cellulose, ethyl cellulose, pectin,sclerotium gum, xanthan gum, pectin, trehelose, gelatin, and so on.

2. Acrylate Polymers

For example, acrylic polymeric thickeners comprised of monomers A and Bwherein A is selected from the group consisting of acrylic acid,methacrylic acid, and mixtures thereof, and B is selected from the groupconsisting of a C₁₋₂₂ alkyl acrylate, a C₁₋₂₂ alky methacrylate, andmixtures thereof are suitable. In one embodiment the A monomer comprisesone or more of acrylic acid or methacrylic acid, and the B monomer isselected from the group consisting of a C₁₋₁₀, most preferably C₁₋₄alkyl acrylate, a C₁₋₁₀, most preferably C₁₋₄ alkyl methacrylate, andmixtures thereof. Most preferably the B monomer is one or more of methylor ethyl acrylate or methacrylate. The acrylic copolymer may be suppliedin an aqueous solution having a solids content ranging from about10-60%, preferably 20-50%, more preferably 25-45% by weight of thepolymer, with the remainder water. The composition of the acryliccopolymer may contain from about 0.1-99 parts of the A monomer, andabout 0.1-99 parts of the B monomer. Acrylic polymer solutions includethose sold by Seppic, Inc., under the tradename Capigel.

Also suitable are acrylic polymeric thickeners that are copolymer of A,B, and C monomers wherein A and B are as defined above, and C has thegeneral formula:

wherein Z is —(CH₂)_(m); wherein m is 1-10, n is 2-3, o is 2-200, and Ris a C₁₀₋₃₀ straight or branched chain alkyl. Examples of the secondarythickening agent above, are copolymers where A and B are defined asabove, and C is CO, and wherein n, o, and R are as above defined.Examples of such secondary thickening agents includeacrylates/steareth-20 methacrylate copolymer, which is sold by Rohm &Haas under the tradename Acrysol ICS-1.

Also suitable are acrylate based anionic amphiphilic polymers containingat least one hydrophilic unit and at least one allyl ether unitcontaining a fatty chain. Preferred are those where the hydrophilic unitcontains an ethylenically unsaturated anionic monomer, morespecificially a vinyl carboxylic acid such as acrylic acid, methacrylicacid or mixtures thereof, and where the allyl ether unit containing afatty chain corresponds to the monomer of formula:CH₂=CR′CH₂OB_(n)Rin which R′ denotes H or CH₃, B denotes the ethylenoxy radical, n iszero or an integer ranging from 1 to 100, R denotes a hydrocarbonradical selected from alkyl, arylalkyl, aryl, alkylaryl and cycloalkylradicals which contain from 8 to 30 carbon atoms, preferably from 10 to24, and even more particularly from 12 to 18 carbon atoms. Morepreferred in this case is where R′ denotes H, n is equal to 10 and Rdenotes a stearyl (C18) radical. Anionic amphiphilic polymers of thistype are described and prepared in U.S. Pat. Nos. 4,677,152 and4,702,844, both of which are hereby incorporated by reference in theirentirety. Among these anionic amphiphilic polymers, polymers formed of20 to 60% by weight acrylic acid and/or methacrylic acid, of 5 to 60% byweight lower alkyl methacrylates, of 2 to 50% by weight allyl ethercontaining a fatty chain as mentioned above, and of 0 to 1% by weight ofa crosslinking agent which is a well-known copolymerizable polyethylenicunsaturated monomer, for instance diallyl phthalate,allyl(meth)acrylate, divinylbenzene, (poly)ethylene glycoldimethacrylate and methylenebisacrylamide. One commercial example ofsuch polymers are crosslinked terpolymers of methacrylic acid, of ethylacrylate, of polyethylene glycol (having 10 EO units) ether of stearylalcohol or steareth-10, in particular those sold by the company AlliedColloids under the names SALCARE SC80 and SALCARE SC90, which areaqueous emulsions containing 30% of a crosslinked terpolymer ofmethacrylic acid, of ethyl acrylate and of steareth-10 allyl ether(40/50/10).

Also suitable are acrylate copolymers such as Polyacrylate-3 which is acopolymer of methacrylic acid, methylmethacrylate, methylstyreneisopropylisocyanate, and PEG-40 behenate monomers; Polyacrylate-10 whichis a copolymer of sodium acryloyldimethyltaurate, sodium acrylate,acrylamide and vinyl pyrrolidone monomers; or Polyacrylate-11, which isa copolymer of sodium acryloyldimethylacryloyldimethyl taurate, sodiumacrylate, hydroxyethyl acrylate, lauryl acrylate, butyl acrylate, andacrylamide monomers.

Also suitable are crosslinked acrylate based polymers where one or moreof the acrylic groups may have substituted long chain alkyl (such as6-40, 10-30, and the like) groups, for example acrylates/C₁₀₋₃₀ alkylacrylate crosspolymer which is a copolymer of C10-30 alkyl acrylate andone or more monomers of acrylic acid, methacrylic acid, or one of theirsimple esters crosslinked with the allyl ether of sucrose or the allylether of pentaerythritol. Such polymers are commonly sold under theCarbopol or Pemulen tradenames.

Particularly suitable as the aqueous phase thickening agent are acrylatebased polymeric thickeners sold by Clariant under the Aristoflextrademark such as Aristoflex AVC, which is ammoniumacryloyldimethyltaurate/VP copolymer; Aristoflex AVL which is the samepolymer has found in AVC dispersed in mixture containing caprylic/caprictriglyceride, trilaureth-4, and polyglyceryl-2 sesquiisostearate; orAristoflex HMB which is ammonium acryloyldimethyltaurate/beheneth-25methacrylate crosspolymer, and the like.

3. High Molecular Weight PEG or Polyglycerins

Also suitable as the aqueous phase thickening agents are variouspolyethylene glycols (PEG) derivatives where the degree ofpolymerization ranges from 1,000 to 200,000. Such ingredients areindicated by the designation “PEG” followed by the degree ofpolymerization in thousands, such as PEG-45M, which means PEG having45,000 repeating ethylene oxide units. Examples of suitable PEGderivatives include PEG 2M, 5M, 7M, 9M, 14M, 20M, 23M, 25M, 45M, 65M,90M, 115M, 160M, 180M, and the like.

Also suitable are polyglycerins which are repeating glycerin moietieswhere the number of repeating moieties ranges from 15 to 200, preferablyfrom about 20-100. Examples of suitable polyglycerins include thosehaving the CFTA names polyglycerin-20, polyglycerin-40, and the like.

E. Botanical Extracts

It may be desirable to include one or more botanical extracts in thecompositions. If so, suggested ranges are from about 0.0001 to 10%,preferably about 0.0005 to 8%, more preferably about 0.001 to 5% byweight of the total composition. Suitable botanical extracts includeextracts from plants (herbs, roots, flowers, fruits, seeds) such asflowers, fruits, vegetables, and so on, including yeast ferment extract,padica pavonica extract, thermus thermophilis ferment extract, camelinasativa seed oil, boswellia serrata extract, olive extract, aribodopsisthaliana extract, acacia dealbata extract, acer saccharinum (sugarmaple), acidopholus, acorus, aesculus, agaricus, agave, agrimonia,algae, aloe, citrus, brassica, cinnamon, orange, apple, blueberry,cranberry, peach, pear, lemon, lime, pea, seaweed, caffeine, green tea,chamomile, willowbark, mulberry, poppy, and those set forth on pages1646 through 1660 of the CTFA Cosmetic Ingredient Handbook, EighthEdition, Volume 2. Further specific examples include, but are notlimited to, Glycyrrhiza Glabra, Salix Nigra, Macrocycstis Pyrifera,Pyrus Malus, Saxifraga Sarmentosa, Vilis Vinifera, Morus Nigra,Scutellaria Baicalensis, Anthemis Nobilis, Salvia Sclarea, RosmarinusOfficianalis, Citrus Medica Limonum, Panax Ginseng, and mixturesthereof.

F. Sunscreens

It may also be desirable to include one or more sunscreens in thecompositions of the invention. Such sunscreens include chemical UVA orUVB sunscreens or physical sunscreens in the particulate form.

1. UVA Chemical Sunscreens

If desired, the composition may comprise one or more UVA sunscreens. Theterm “UVA sunscreen” means a chemical compound that blocks UV radiationin the wavelength range of about 320 to 400 nm. Preferred UVA sunscreensare dibenzoylmethane compounds having the general formula

wherein R₁ is H, OR and NRR wherein each R is independently H, C₁₋₂₀straight or branched chain alkyl; R₂ is H or OH; and R₃ is H, C₁₋₂₀straight or branched chain alkyl.

Preferred is where R₁ is OR where R is a C₁₋₂₀ straight or branchedalkyl, preferably methyl; R₂ is H; and R₃ is a C₁₋₂₀ straight orbranched chain alkyl, more preferably, butyl.

Examples of suitable UVA sunscreen compounds of this general formulainclude 4-methyldibenzoylmethane, 2-methyldibenzoylmethane,4-isopropyldibenzoylmethane, 4-tert-butyldibenzoylmethane,2,4-dimethyldibenzoylmethane, 2,5-dimethyldibenzoylmethane,4,4′diisopropylbenzoylmethane, 4-tert-butyl-4′-methoxydibenzoylmethane,4,4′-diisopropylbenzoylmethane,2-methyl-5-isopropyl-4′-methoxydibenzoymethane,2-methyl-5-tert-butyl-4′-methoxydibenzoylmethane, and so on.Particularly preferred is 4-tert-butyl-4′-methoxydibenzoylmethane, alsoreferred to as Avobenzone. Avobenzone is commercial available fromGivaudan-Roure under the trademark Parsol 1789, and Merck & Co. underthe tradename Eusolex 9020.

The composition may contain from about 0.001-20%, preferably 0.005-5%,more preferably about 0.005-3% by weight of the composition of UVAsunscreen. In the preferred embodiment of the invention the UVAsunscreen is Avobenzone, and it is present at not greater than about 3%by weight of the total composition.

2. UVB Chemical Sunscreens

The term “UVB sunscreen” means a compound that blocks UV radiation inthe wavelength range of from about 290 to 320 nm. A variety of UVBchemical sunscreens exist including alpha-cyano-beta,beta-diphenylacrylic acid esters as set forth in U.S. Pat. No. 3,215,724, which ishereby incorporated by reference in its entirety. One particular exampleof an alpha-cyano-beta,beta-diphenyl acrylic acid ester is Octocrylene,which is 2-ethylhexyl 2-cyano-3,3-diphenylacrylate. In certain cases thecomposition may contain no more than about 110% by weight of the totalcomposition of octocrylene. Suitable amounts range from about 0.001-10%by weight. Octocrylene may be purchased from BASF under the tradenameUvinul N-539.

Other suitable sunscreens include benzylidene camphor derivatives as setforth in U.S. Pat. No. 3,781,417, which is hereby incorporated byreference in its entirety. Such benzylidene camphor derivatives have thegeneral formula:

wherein R is p-tolyl or styryl, preferably styryl. Particularlypreferred is 4-methylbenzylidene camphor, which is a lipid soluble UVBsunscreen compound sold under the tradename Eusolex 6300 by Merck.

Also suitable are cinnamate derivatives having the general formula:

wherein R and R₁ are each independently a C₁₋₂₀ straight or branchedchain alkyl. Preferred is where R is methyl and R₁ is a branched chainC₁₋₁₀, preferably C₈ alkyl. The preferred compound is ethylhexylmethoxycinnamate, also referred to as Octoxinate or octylmethoxycinnamate. The compound may be purchased from GivaudanCorporation under the tradename Parsol MCX, or BASF under the tradenameUvinul MC 80. Also suitable are mono-, di-, and triethanolaminederivatives of such methoxy cinnamates including diethanolaminemethoxycinnamate. Cinoxate, the aromatic ether derivative of the abovecompound is also acceptable. If present, the Cinoxate should be found atno more than about 3% by weight of the total composition.

Also suitable as UVB screening agents are various benzophenonederivatives having the general formula:

wherein R through R₉ are each independently H, OH, NaO₃S, SO₃H, SO₃Na,Cl, R″, OR″ where R″ is C₁₋₂₀ straight or branched chain alkyl Examplesof such compounds include Benzophenone 1, 2, 3, 4, 5, 6, 7, 8, 9, 10,11, and 12. Particularly preferred is where the benzophenone derivativeis Benzophenone 3 (also referred to as Oxybenzone), Benzophenone 4 (alsoreferred to as Sulisobenzone), Benzophenone 5 (Sulisobenzone Sodium),and the like. Most preferred is Benzophenone 3.

Also suitable are certain menthyl salicylate derivatives having thegeneral formula:

wherein R₁, R₂, R₃, and R₄ are each independently H, OH, NH₂, or C₁₋₂₀straight or branched chain alkyl. Particularly preferred is where R₁,R₂, and R₃ are methyl and R₄ is hydroxyl or NH₂, the compound having thename homomenthyl salicylate (also known as Homosalate) or menthylanthranilate. Homosalate is available commercially from Merck under thetradename Eusolex HMS and menthyl anthranilate is commercially availablefrom Haarmann & Reimer under the tradename Heliopan. If present, theHomosalate should be found at no more than about 15% by weight of thetotal composition.

Various amino benzoic acid derivatives are suitable UVB absorbersincluding those having the general formula:

wherein R₁, R₂, and R₃ are each independently H, C₁₋₂₀ straight orbranched chain alkyl which may be substituted with one or more hydroxygroups. Particularly preferred is wherein R₁ is H or C₁₋₈ straight orbranched alkyl, and R₂ and R₃ are H, or C₁₋₈ straight or branched chainalkyl. Particularly preferred are PABA, ethyl hexyl dimethyl PABA(Padimate O), ethyldihydroxypropyl PABA, and the like. If presentPadimate O should be found at no more than about 8% by weight of thetotal composition.

Salicylate derivatives are also acceptable UVB absorbers. Such compoundshave the general formula: wherein R is a straight or branched chainalkyl, including derivatives of the above compound formed from mono-,di-, or triethanolamines. Particular preferred are octyl salicylate,TEA-salicylate, DEA-salicylate, and mixtures thereof.

Generally, the amount of the UVB chemical sunscreen present may rangefrom about 0.001-45%, preferably 0.005-40%, more preferably about0.01-35% by weight of the total composition.

If desired, the compositions of the invention may be formulated to havea certain SPF (sun protective factor) values ranging from about 1-50,preferably about 2-45, most preferably about 5-30. Calculation of SPFvalues is well known in the art. Preferably, the claimed compositionshave SPF values greater than 4.

G. Particulate Materials

The compositions of the invention may contain particulate materials inthe form of pigments, inert particulates, or mixtures thereof. Ifpresent, suggested ranges are from about 0.1-75%, preferably about0.5-70%, more preferably about 0.1-65% by weight of the totalcomposition. In the case where the composition may comprise mixtures ofpigments and powders, suitable ranges include about 0.01-75% pigment and0.1-75% powder, such weights by weight of the total composition.

1. Powders

The particulate matter may be colored or non-colored (for example white)non-pigmentatious powders. Suitable non-pigmentatious powders includebismuth oxychloride, titanated mica, fumed silica, spherical silica,polymethylmethacrylate, micronized teflon, boron nitride, acrylatecopolymers, aluminum silicate, aluminum starch octenylsuccinate,bentonite, calcium silicate, cellulose, chalk, corn starch, diatomaceousearth, fuller's earth, glyceryl starch, hectorite, hydrated silica,kaolin, magnesium aluminum silicate, magnesium trisilicate,maltodextrin, montmorillonite, microcrystalline cellulose, rice starch,silica, talc, mica, titanium dioxide, zinc laurate, zinc myristate, zincrosinate, alumina, attapulgite, calcium carbonate, calcium silicate,dextran, kaolin, nylon, silica silylate, silk powder, sericite, soyflour, tin oxide, titanium hydroxide, trimagnesium phosphate, walnutshell powder, or mixtures thereof. The above mentioned powders may besurface treated with lecithin, amino acids, mineral oil, silicone, orvarious other agents either alone or in combination, which coat thepowder surface and render the particles more lipophilic in nature.

2. Pigments

The particulate materials may comprise various organic and/or inorganicpigments. The organic pigments are generally various aromatic typesincluding azo, indigoid, triphenylmethane, anthroquinone, and xanthinedyes which are designated as D&C and FD&C blues, browns, greens,oranges, reds, yellows, etc. Organic pigments generally consist ofinsoluble metallic salts of certified color additives, referred to asthe Lakes. Inorganic pigments include iron oxides, ultramarines,chromium, chromium hydroxide colors, and mixtures thereof. Iron oxidesof red, blue, yellow, brown, black, and mixtures thereof are suitable.

H. Preservatives

The composition may contain 0.001-8%, preferably 0.01-6%, morepreferably 0.05-5% by weight of the total composition of preservatives.A variety of preservatives are suitable, including such as benzoic acid,benzyl alcohol, benzylhemiformal, benzylparaben,5-bromo-5-nitro-1,3-dioxane, 2-bromo-2-nitropropane-1,3-diol, butylparaben, phenoxyethanol, methyl paraben, propyl paraben, diazolidinylurea, calcium benzoate, calcium propionate, caprylyl glycol, biguanidederivatives, phenoxyethanol, captan, chlorhexidine diacetate,chlorhexidine digluconate, chlorhexidine dihydrochloride,chloroacetamide, chlorobutanol, p-chloro-m-cresol, chlorophene,chlorothymol, chloroxylenol, m-cresol, o-cresol, DEDM Hydantoin, DEDMHydantoin dilaurate, dehydroacetic acid, diazolidinyl urea,dibromopropamidine diisethionate, DMDM Hydantoin, and the like. In onepreferred embodiment the composition is free of parabens.

I. Vitamins and Antioxidants

The compositions of the invention, may contain vitamins and/orcoenzymes, as well as antioxidants. If so, 0.001-10%, preferably0.01-8%, more preferably 0.05-5% by weight of the total composition aresuggested. Suitable vitamins include ascorbic acid and derivativesthereof, the B vitamins such as thiamine, riboflavin, pyridoxin, and soon, as well as coenzymes such as thiamine pyrophoshate, flavin adenindinucleotide, folic acid, pyridoxal phosphate, tetrahydrofolic acid, andso on. Also Vitamin A and derivatives thereof are suitable. Examples areVitamin A palmitate, acetate, or other esters thereof, as well asVitamin A in the form of beta carotene. Also suitable is Vitamin E andderivatives thereof such as Vitamin E acetate, nicotinate, or otheresters thereof. In addition, Vitamins D and K are suitable.

Suitable antioxidants are ingredients which assist in preventing orretarding spoilage. Examples of antioxidants suitable for use in thecompositions of the invention are potassium sulfite, sodium bisulfite,sodium erythrobate, sodium metabisulfite, sodium sulfite, propylgallate, cysteine hydrochloride, butylated hydroxytoluene, butylatedhydroxyanisole, and so on.

V. The Cosmetic Compositions

The emulsion cosmetic compositions containing the resveratrolderivatives may be found in a variety of forms, such as skin creams orlotions, or color cosmetic compositions such as foundation makeup,mascara, lip color, blush, eyeshadow, and the like. The resveratrolderivative may be found in the water phase or the oil phase of theemulsion depending on the type of derivative. For example, certainhydrophilic derivatives such as resveratrol triphosphate, resveratroltrisulfonate, and the like are water soluble and will generally be foundin the water phase of the emulsion. Certain other derivatives arelipophilic in nature and will more likely be found in the oil phase ofthe emulsion.

Typical skin creams or lotions comprise from about 5-98% water, 1-85%oil, and from about 0.1 to 20% of one or more surfactants. Preferablythe surfactants are nonionic and may be in the form of silicones ororganic nonionic surfactants.

Typical color cosmetic compositions such as foundations, blush,eyeshadow and the like will preferably contain from about 5-98% water,1-85% oil, and from about 0.1 to 20% of one or more surfactants inaddition to from about 0.1 to 65% of particulates that are pigments or acombination of pigments and powders.

Typical mascara compositions generally contain from about 5-98% water,1-85% oil, and from about 0.1 to 20% surfactant in addition to naturalor synthetic polymers that are film forming, such as aqueous dispersionsof acrylic copolymers, aqueous dispersions of polyurethane, or siliconeresins.

The emulsion compositions of the invention may be found in a widevariety of other forms.

The invention will be further described in connection with the followingexamples which are set forth for the purposes of illustration only.

EXAMPLE 1

Skin treatment oil-in-water (1), and oil-in-water-in-silicone oil (2),creams were prepared as follows:

w/w % Ingredient 1 2 Water QS QS Hydroxyethyl urea 0.50 Hyaluronic acid9.00 9.00 Disodium EDTA 0.12 Creatine 0.05 Sucrose 0.50 Caffeine 0.20Caprylyl glycol 0.40 0.28 Caprylic/capric triglyceride/cetylalcohol/C12-20 acid 4.00 PEG-8 ester PEG-100 stearate 1.20 C12-20 acidPEG-8 ester 4.96 Caprylic/capric triglyceride 0.55 Behenyl alcohol 0.50Coco caprylate caprate 5.10 Sweet almond oil 0.10 Dimethicone, 100 cst.2.50 Dimethicone, 6 cst 5.00 Dimethicone (silicone gum/20 cstdimethicone blend) 8.00 Dimethicone/polysilicone 11 6.00Dimethicone/dimethicone PEG-10/15 crosspolymer 1.00 Lauryl PEG-9polydimethylsiloxyethyl dimethicone 1.00 Sesame oil 0.10 Potassium cetylphosphate 0.50 Apricot kernel oil 0.10 Wheat bran extract/olive extract0.20 0.20 Cholesterol 0.20 Linoleic acid 0.20 Cholesterol/potassiumsulfate 0.20 Theobroma grandiflorum seed butter 1.40 Lauryl PCA 0.011.00 Dimethicone 1.50 Phenoxyethanol 0.70 0.60 Water/polyaminopropylbiguanide 0.40 Glycerin 2.00 Butylene glycol 1.00 Hexylene glycol 0.05Mica/titanium dioxide 1.00 0.75 Mica/titanium dioxide/triethoxycaprylylsilane 0.50 Pearl powder 0.001 Silica 0.50 30% aqueous sodium hydroxide0.35 Trehalose 0.50 N-acetyl glucosamine 1.00 1.00 Water/purifiedaribodopsis thaliana extract/lecithin 0.50 1.00 Aqueous solution acetylhexapeptide-8 1.00 1.00 Yeast ferment extract 1.00 1.00Water/lecithin/micrococcus lysate 0.50 0.50 Milkprotein/lactose/glucose/fructose 0.50 0.50 Saccharide isomerate 0.50Whey protein 0.50 0.560 Water/butylene glycol/lecithin/lauryldimonium1.00 1.00 hydroxypropyl hydrolyzed soy protein/lecithin/ xanthangum/ascorbyl tocopheryl maleate Glycerin/padina povonica extract 0.100.10 Thermus thermophillus ferment/glycerin 0.05 Camelina sativa seedoil 0.05 Water/gold/hydrolyzed wheat protein 0.001Sorbitol/water/ascophyllum nodosum extract/asparagopsis 0.25 armataextract Butylene glycol 0.50 Boswellia serrata extract 0.05 Calophylluminophyllum (tamanu) seed oil 0.05 Fragrance 0.20 FD&C yellow No. 5 (1%aqueous solution) 0.05 Aminomethyl propanol 0.03 Sodim phosphate dibasic(10% aqueous solution) 0.75 Citric acid (10% aqueous solution) 0.008Sodium acrylate/sodium acryloyldimethyl taurate 1.00 1.00copolymer/hydrogenated polydecene/laureth-8 Ammoniumacrylodimethyltaurate/VP copolymer 0.70 Water/butylene glycol/decarboxycarnosine HCl 0.50 Trisodium resveratrol triphosphate 0.50 0.50

The composition was prepared by combining the water phase and oil phaseingredients separately, then emulsifying to form an emulsion.

EXAMPLE 2

A water-in-silicone-oil emulsion skin serum was prepared as follows:

Ingredient w/w % Dimethicone/dimethicone PEG-10/15 crosspolymer 4.00Dimethicone/dimethiconol 1.00 Dimethicone, 6 cst. 6.00 Trisiloxane (1.0cst) 16.00  Water QS Phenoxyethanol 0.50 Caprylylglycol/phenoxyethanol/hexylene glycol/iodopropynyl 0.50 butylcarbamateWater/polyaminobiguanide 0.20 Trisodium resveratrol triphosphate 0.50Butylene glycol 2.00 Glycerin 10.00  Sodium citrate 0.50

The composition was prepared by combining the oil phase ingredients andwater phase ingredients separately, then mixing well to emulsify.

EXAMPLE 3

Oil-in-water (O/W) and water-in-oil (W/O) emulsion mascaras wereprepared as follows:

w/w % Ingredient O/W W/O Ethylenediamine/Stearyl Dimer TallateCopolymer - 10.   12.00  Uniclear 100VG, Arizona Chemical PEG-30Dipolyhydroxystearate 3.00 Sorbitan tristearate 1.00 — Glycerylstearate/PEG-100 stearate 1.00 — Stearic acid 4.00 3.00 Cetylacetate/Acetylated lanolin alcohol 1.00 Dioctyl adipate/octylstearate/octyl palmitate 1.00 — Stearamide MEA stearate 3.00 — Glycerylolivate — 0.50 Dioctyl malate — 1.00 Dimethicone 2.50 — Cyclomethicone5.00 — Isododecane 11.00  38.0  Ethanol 0.50 — Water QS QS Silica 1.00 —Polysorbate 20 2.00 — Acacia gum 0.25 — Black iron oxide 8.00 10.00 Polyvinylpyrrolidone 1.00 — 4′-5′dihydroxystilbene-3-O-beta-mono-D-glucoside 0.50 — Shellac 2.00 —Acrylic copolymer solids dispersed in aqueous solution 5.00 7.00Preservatives 0.80 —

The mascaras were made by combining the oily phase ingredients exceptfor the cyclomethicone and dimethicone and heating to about 90° C. untilsolids melted. The cyclomethicone and dimethicone were added to themixture and the heat maintained at about 60° C. The water phaseingredients were combined and heated to about 60° C. and combined withthe mixture. The phases were emulsified to form the final mixture.

EXAMPLE 4

Emulsion foundation makeup compositions were prepared as follows:

Ingredient w/w % Cyclomethicone 16.90 Polysilicone-11 5.00Cyclomethicone/dimethiconol 1.00 Dimethicone copolyol 1.50 Sorbitansesquioleate 1.50 Phenyl trimethicone 10.00 Dimethicone 10.00Resveratrol tripalmitate 0.50 Red Iron Oxide treated with methicone 0.50Yellow iron oxide treated with methicone 1.22 Black iron oxide treatedwith methicone 0.13 Titanium dioxide coated with methicone 8.06 Water QSButylene glycol 5.00 Xanthan gum 0.10 Magnesium sulfate 1.00 Laureth-70.25

The water, oil and pigment phases were separately prepared by low shearmixing. The phases were combined with high shear blending to form afoundation makeup composition.

We claim:
 1. An emulsion cosmetic composition comprising estersconsisting of a mixture of: 3-phosphate-5,4′-dihydroxystilbene,4′-phosphate-3,5′-hydroxystilbene, 3,5-diphosophate-4′-hydroxystilbene,3,4′-diphosphate-5-hydroxystilbene; and 3,5,4′-triphosphate stilbene;and at least one DNA repair enzyme.
 2. The composition of claim 1wherein the mixture is dispersed or solubilized in the aqueous phase ofthe emulsion.
 3. The composition of claim 1 wherein the mixture isreacted with sodium hydroxide and the DNA repair enzyme is selected fromMicrococcus lysate, Arabidopsis thaliana extract and mixtures thereof.4. The composition of claim 1 wherein the composition is a skin cream orlotion and comprises a mixture of volatile and nonvolatile silicones, atleast one ester oil, and at least one humectant.
 5. The composition ofclaim 1 wherein the composition is a skin cream or lotion and comprisesat least one volatile silicone, at least one oil phase structuringagent, at least one aqueous phase structuring agent.
 6. The compositionof claim 1 wherein the composition is a foundation makeup compositionwherein the oil phase comprises a mixture of volatile and nonvolatilesilicones, at least one humectant, and particulates.
 7. The compositionof claim 6 wherein the particulates comprise a mixture of pigments andpowders.
 8. The composition of claim 1 which is a mascara.
 9. Thecomposition of claim 1 which is a skin cream, lotion, or makeup, furthercomprising a chemical sunscreen.
 10. The composition of claim 9 whereinthe chemical sunscreen is a UVA sunscreen.
 11. A method formanufacturing an emulsion cosmetic composition for delivering aphosphate esters of resveratrol to skin, said phosphate estersconsisting of a mixture of: 3-phosphate-5,4′-dihydroxystilbene;4′-phosphate-3,5-dihydroxystilbene; 3,5-diphosphate-4′-hydroxystilbene;3,4′-diphosphate-5-hydroxystilbene; and 3,5,4′-triphosphate stilbene;comprising separately combining the oil phase and the water phaseingredients, solvating or dispersing the phosphate esters of resveratrolinto the water phase or the oil phase, then emulsifying the phases tocreate a water and oil emulsion where the phosphate esters arehydrolytically stable in the emulsion but hydrolyzes to activeresveratrol when the emulsion is applied to skin.
 12. The method ofclaim 11 wherein the phosphate esters of resveratrol are neutralizedwith sodium hydroxide.
 13. The method of claim 12 wherein the phosphateesters of resveratrol are neutralized with sodium hydroxide prior tobeing solvated or dispersed into the emulsion.